Literature DB >> 19081987

Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes.

Grazia Papini1, Simone Alidori, Jason S Lewis, David E Reichert, Maura Pellei, Giancarlo Gioia Lobbia, Gráinne B Biddlecombe, Carolyn J Anderson, Carlo Santini.   

Abstract

The aim of this work was to prepare a novel class of (64)Cu(II) labeled complexes with the new macrocyclic ligands 1,10-dithia-4,7-diazacyclododecane-3,8-dicarboxylic acid (NEC-SE, 1), 1,10-dithia-4,7-diazacyclotridecane-3,8-dicarboxylic acid (NEC-SP, 2) and 1,10-dithia-4,7-diazacyclotetradecane-3,8-dicarboxylic acid, (NEC-SB, 3 ) to evaluate the usefulness of these macrocycles for potential utility as (64)Cu(II) chelators. The corresponding non-radioactive complexes [Cu(NEC-SE)] x 3H(2)O (4), [Cu(NEC-SP)] x 3H(2)O (5) and [Cu(NEC-SB)] (6) were prepared and their (64)Cu-analogs, [(64)Cu(NEC-SE)] (7) and [(64)Cu(NEC-SP)] (8) and [(64)Cu(NEC-SB)] (9) were produced in >98% radiochemical purity. Rats were injected with complex 7, 8 or 9 and were euthanized at 1, 4 and 24 h. All three complexes are cleared from the blood over the first hour following injection but there is poor clearance of this activity over 24 h. A similar pattern of retention was noted in the liver where the levels of activity in this tissue at 1 h are not statistically different from those at 24 h. Molecular mechanics and DFT studies were performed on the complexes in order to gain insight into the lower stability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19081987      PMCID: PMC4418490          DOI: 10.1039/b808831d

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  31 in total

1.  In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V.

Authors:  D J Yang; A Azhdarinia; P Wu; D F Yu; W Tansey; S K Kalimi; E E Kim; D A Podoloff
Journal:  Cancer Biother Radiopharm       Date:  2001-02       Impact factor: 3.099

Review 2.  Positron-emitting isotopes produced on biomedical cyclotrons.

Authors:  Paul McQuade; Douglas J Rowland; Jason S Lewis; Michael J Welch
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 3.  Labelling monoclonal antibodies with macrocyclic radiometal complexes. A challenge for coordination chemists.

Authors:  Thomas A Kaden
Journal:  Dalton Trans       Date:  2006-07-06       Impact factor: 4.390

4.  Noninvasive assessment of tumor hypoxia with 99mTc labeled metronidazole.

Authors:  D J Yang; S Ilgan; T Higuchi; F Zareneyrizi; C S Oh; C W Liu; E E Kim; D A Podoloff
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

5.  N,N'-ethylene-di-L-cysteine (EC) complexes of Ga(III) and In(III): molecular modeling, thermodynamic stability and in vivo studies.

Authors:  C J Anderson; C S John; Y J Li; R D Hancock; T J McCarthy; A E Martell; M J Welch
Journal:  Nucl Med Biol       Date:  1995-02       Impact factor: 2.408

6.  64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.

Authors:  C J Anderson; F Dehdashti; P D Cutler; S W Schwarz; R Laforest; L A Bass; J S Lewis; D W McCarthy
Journal:  J Nucl Med       Date:  2001-02       Impact factor: 10.057

Review 7.  Copper chelation chemistry and its role in copper radiopharmaceuticals.

Authors:  T J Wadas; E H Wong; G R Weisman; C J Anderson
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

8.  Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals.

Authors:  A M Verbruggen; D L Nosco; C G Van Nerom; G M Bormans; P J Adriaens; M J De Roo
Journal:  J Nucl Med       Date:  1992-04       Impact factor: 10.057

9.  Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent.

Authors:  M K Moi; C F Meares; M J McCall; W C Cole; S J DeNardo
Journal:  Anal Biochem       Date:  1985-07       Impact factor: 3.365

10.  Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging.

Authors:  C J Anderson; P A Rocque; C J Weinheimer; M J Welch
Journal:  Nucl Med Biol       Date:  1993-05       Impact factor: 2.408

View more
  3 in total

Review 1.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  VPAC1 Targeted 64Cu-TP3805 kit preparation and its evaluation.

Authors:  Sushil K Tripathi; Pardeep Kumar; Edouard J Trabulsi; Sung Kim; Peter A McCue; Charles Intenzo; Adam Berger; Leonard Gomella; Mathew L Thakur
Journal:  Nucl Med Biol       Date:  2017-05-03       Impact factor: 2.408

3.  Revisiting dithiadiaza macrocyclic chelators for copper-64 PET imaging.

Authors:  Sergey Shuvaev; Elizaveta A Suturina; Nicholas J Rotile; Andrei Astashkin; Christopher J Ziegler; Alana W Ross; Tia L Walker; Peter Caravan; Ian S Taschner
Journal:  Dalton Trans       Date:  2020-10-20       Impact factor: 4.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.